With a $32 million loan in hand, AgaMatrix said this week it plans to reorganize the companies into two entities – AgaMatrix, Inc. and WaveForm Technologies.
The holding company raised $32 million from Prospect Capital Corp. and said it will use the funds to support sales and marketing, product development and clinical trial activities for its blood glucose monitoring products and closed-loop insulin delivery solutions.
Get the full story at our sister site, Drug Delivery Business News.
The post AgaMatrix lands $32m loan for split appeared first on MassDevice.